Meeting
2023 ASCO Genitourinary Cancers Symposium
Clinical and molecular features of ATM and BRCA2 mutations in metastatic prostate cancer.
Authors
Xiaolei Shi
University of Minnesota, Minneapolis, MN
Xiaolei Shi , Justin Hwang , Julie McGrath , Hannah E. Bergom , Abderrahman Day , Eamon Toye , Rachel Passow , Sydney Tape , Allison Makovec , John R Lozada , Charles J. Ryan , Benedito A. Carneiro , Rana R. McKay , Chadi Nabhan , W. Michael Korn , Emmanuel S. Antonarakis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 245)
DOI
10.1200/JCO.2023.41.6_suppl.245
Abstract #
245
Poster Bd #
J8
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Differential activity of PARP inhibitors in BRCA1- versus BRCA2-altered metastatic castration-resistant prostate cancer (mCRPC).
First Author: Fadi Taza
Poster
2018 Genitourinary Cancers Symposium
Clinical utility of Foundation One tissue molecular profiling in men with metastatic prostate cancer.
First Author: Jason Zhu
Poster
2021 ASCO Annual Meeting
Association of ATM mutations in metastatic prostate cancer with differential genomic alteration profiles from homologous recombination deficient and proficient tumors.
First Author: Charles J. Ryan
Poster
2021 ASCO Annual Meeting
Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.
First Author: Joseph W. Kim